On the public citation graph
Neighbouring modifications interfere with the detection of phosphorylated alpha-synuclein at Serine 129: Revisiting the specificity of pS129 antibodies
0 signed · 103 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/acn3.45openalex-snapshot
LRRK 2 R1441G mice are more liable to dopamine depletion and locomotor inactivity
inferredcites →https://doi.org/10.1002/cne.24468openalex-snapshot
Sensitivity and specificity of phospho‐Ser129 α‐synuclein monoclonal antibodies
inferredcites →https://doi.org/10.1002/jnr.21310openalex-snapshot
Accumulation of phosphorylated α‐synuclein in dopaminergic neurons of transgenic mice that express human α‐synuclein
inferredcites →https://doi.org/10.1006/exnr.2000.7527openalex-snapshot
In Situ and in Vitro Study of Colocalization and Segregation of α-Synuclein, Ubiquitin, and Lipids in Lewy Bodies
inferredcites →https://doi.org/10.1007/978-1-4939-2978-8_1openalex-snapshot
Semisynthesis and Enzymatic Preparation of Post-translationally Modified α-Synuclein
inferredcites →https://doi.org/10.1007/pl00007441openalex-snapshot
C-terminal α-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders
inferredcites →https://doi.org/10.1007/s00401-002-0545-5openalex-snapshot
NACP/α-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC)
inferredcites →https://doi.org/10.1007/s00401-002-0622-9openalex-snapshot
Glial involvement in diffuse Lewy body disease
inferredcites →https://doi.org/10.1007/s00401-003-0811-1openalex-snapshot
Accumulation of phosphorylated a-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy
inferredcites →https://doi.org/10.1007/s00401-007-0244-3openalex-snapshot
Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease
inferredcites →https://doi.org/10.1007/s00401-008-0375-1openalex-snapshot
Characterization of antibodies that selectively detect α-synuclein in pathological inclusions
inferredcites →https://doi.org/10.1007/s00401-009-0523-2openalex-snapshot
Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium
inferredcites →https://doi.org/10.1007/s00401-013-1096-7openalex-snapshot
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?
inferredcites →https://doi.org/10.1007/s00401-014-1268-0openalex-snapshot
Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice
inferredcites →https://doi.org/10.1007/s00401-014-1284-0openalex-snapshot
Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology
inferredcites →https://doi.org/10.1007/s00401-015-1485-1openalex-snapshot
Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
inferredcites →https://doi.org/10.1007/s00401-019-01977-2openalex-snapshot
α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease
inferredcites →https://doi.org/10.1007/s00401-021-02329-9openalex-snapshot
The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson’s disease brain as revealed by multicolor STED microscopy
inferredcites →https://doi.org/10.1007/s004010100390openalex-snapshot
Cortical Lewy body pathology in the diagnosis of dementia
inferredcites →https://doi.org/10.1007/s00441-018-2839-5openalex-snapshot
ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences
inferredcites →https://doi.org/10.1007/s11064-011-0527-xopenalex-snapshot
Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method
inferredcites →https://doi.org/10.1007/s12035-012-8280-yopenalex-snapshot
The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
inferredcites →https://doi.org/10.1016/j.bbagen.2015.10.007openalex-snapshot
Cellular response of human neuroblastoma cells to α-synuclein fibrils, the main constituent of Lewy bodies
inferredcites →https://doi.org/10.1016/j.expneurol.2012.11.020openalex-snapshot
Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
inferredcites →https://doi.org/10.1016/j.isci.2020.100910openalex-snapshot
α-Synuclein Translocates to the Nucleus to Activate Retinoic-Acid-Dependent Gene Transcription
inferredcites →https://doi.org/10.1016/j.nbd.2015.06.003openalex-snapshot
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
inferredcites →https://doi.org/10.1016/j.nbd.2018.11.015openalex-snapshot
Pα-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria
inferredcites →https://doi.org/10.1016/j.nbd.2020.105086openalex-snapshot
How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology
inferredcites →https://doi.org/10.1016/j.neulet.2020.134899openalex-snapshot
Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies
inferredcites →https://doi.org/10.1016/j.neurobiolaging.2019.08.007openalex-snapshot
Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology
inferredcites →https://doi.org/10.1016/j.neurobiolaging.2021.05.012openalex-snapshot
Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction
inferredcites →https://doi.org/10.1016/j.neuron.2011.08.033openalex-snapshot
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
inferredcites →https://doi.org/10.1016/j.neuron.2019.12.004openalex-snapshot
Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological α-Synuclein Insult
inferredcites →https://doi.org/10.1016/j.neuroscience.2009.03.002openalex-snapshot
Nuclear and neuritic distribution of serine-129 phosphorylated α-synuclein in transgenic mice
inferredcites →https://doi.org/10.1016/j.neuroscience.2011.10.042openalex-snapshot
α-synuclein phosphorylation and truncation are normal events in the adult human brain
inferredcites →https://doi.org/10.1016/s0002-9440(10)64781-5openalex-snapshot
Widespread Nitration of Pathological Inclusions in Neurodegenerative Synucleinopathies
inferredcites →https://doi.org/10.1016/s0022-510x(03)00144-8openalex-snapshot
A paced visual serial addition test for fMRI
inferredcites →https://doi.org/10.1016/s0197-4580(02)00065-9openalex-snapshot
Staging of brain pathology related to sporadic Parkinson’s disease
inferredcites →https://doi.org/10.1021/acs.jproteome.8b00982openalex-snapshot
Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
inferredcites →https://doi.org/10.1021/bi0341152openalex-snapshot
Nuclear Localization of α-Synuclein and Its Interaction with Histones
inferredcites →https://doi.org/10.1021/ja210866jopenalex-snapshot
Elucidating the Role of C-Terminal Post-Translational Modifications Using Protein Semisynthesis Strategies: α-Synuclein Phosphorylation at Tyrosine 125
inferredcites →https://doi.org/10.1021/ja5131726openalex-snapshot
Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson’s Disease via Protein Semisynthesis and Mutagenesis
inferredcites →https://doi.org/10.1038/cdd.2015.79openalex-snapshot
Fibril growth and seeding capacity play key roles in α-synuclein-mediated apoptotic cell death
inferredcites →https://doi.org/10.1038/d41586-020-02549-1openalex-snapshot
When antibodies mislead: the quest for validation
inferredcites →https://doi.org/10.1038/nature14547openalex-snapshot
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
inferredcites →https://doi.org/10.1038/ncb748openalex-snapshot
α-Synuclein is phosphorylated in synucleinopathy lesions
inferredcites →https://doi.org/10.1038/nprot.2014.143openalex-snapshot
Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite–like aggregates
inferredcites →https://doi.org/10.1038/s41467-018-05971-2openalex-snapshot
Cryo-EM of full-length α-synuclein reveals fibril polymorphs with a common structural kernel
inferredcites →https://doi.org/10.1038/s41467-020-16564-3openalex-snapshot
Extent of N-terminus exposure of monomeric alpha-synuclein determines its aggregation propensity
inferredcites →https://doi.org/10.1038/s41531-023-00491-3openalex-snapshot
Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis
inferredcites →https://doi.org/10.1038/s41586-020-2317-6openalex-snapshot
Structures of α-synuclein filaments from multiple system atrophy
inferredcites →https://doi.org/10.1038/srep05797openalex-snapshot
Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry
inferredcites →https://doi.org/10.1046/j.1471-4159.1999.02093.xopenalex-snapshot
α‐Synuclein Immunoisolation of Glial Inclusions from Multiple System Atrophy Brain Tissue Reveals Multiprotein Components
inferredcites →https://doi.org/10.1073/pnas.0307446101openalex-snapshot
Nitric oxide, oxidants, and protein tyrosine nitration
inferredcites →https://doi.org/10.1073/pnas.0908005106openalex-snapshot
Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells
inferredcites →https://doi.org/10.1073/pnas.1315654110openalex-snapshot
Synthetic polyubiquitinated α-Synuclein reveals important insights into the roles of the ubiquitin chain in regulating its pathophysiology
inferredcites →https://doi.org/10.1073/pnas.1606791113openalex-snapshot
Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity
inferredcites →https://doi.org/10.1073/pnas.1713849115openalex-snapshot
Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s disease
inferredcites →https://doi.org/10.1073/pnas.1913904117openalex-snapshot
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
inferredcites →https://doi.org/10.1073/pnas.1922741117openalex-snapshot
Parkinson’s disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM
inferredcites →https://doi.org/10.1073/pnas.95.11.6469openalex-snapshot
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
inferredcites →https://doi.org/10.1074/jbc.m010316200openalex-snapshot
α-Synuclein Is Phosphorylated by Members of the Src Family of Protein-tyrosine Kinases
inferredcites →https://doi.org/10.1074/jbc.m111.318949openalex-snapshot
α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer
inferredcites →https://doi.org/10.1074/jbc.m113.457408openalex-snapshot
Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy
inferredcites →https://doi.org/10.1074/jbc.m114.610774openalex-snapshot
Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo
inferredcites →https://doi.org/10.1074/jbc.m600933200openalex-snapshot
Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease
inferredcites →https://doi.org/10.1074/jbc.ra118.005603openalex-snapshot
Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions
inferredcites →https://doi.org/10.1080/19420862.2020.1794421openalex-snapshot
The Antibody Society’s antibody validation webinar series
inferredcites →https://doi.org/10.1093/hmg/ddx114openalex-snapshot
Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage
inferredcites →https://doi.org/10.1093/hmg/ddy326openalex-snapshot
Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein
inferredcites →https://doi.org/10.1093/jnen/62.12.1241openalex-snapshot
Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62
inferredcites →https://doi.org/10.1097/00005072-199804000-00005openalex-snapshot
Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinsonʼs Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity
inferredcites →https://doi.org/10.1101/2020.11.11.378752openalex-snapshot
Detection and Purification of Lewy Pathology from Formalin Fixed Primary Human Tissue Using Biotinylation by Antigen Recognition
inferredcites →https://doi.org/10.1101/2021.09.28.461511openalex-snapshot
Specific Detection of Endogenous S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay
inferredcites →https://doi.org/10.1101/2021.10.20.465125openalex-snapshot
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
inferredcites →https://doi.org/10.1101/2021.11.21.469421openalex-snapshot
A novel mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein fibrils and recapitulates its pathological diversity
inferredcites →https://doi.org/10.1101/500058openalex-snapshot
The making of a Lewy body: the role of alpha-synuclein post-fibrillization modifications in regulating the formation and the maturation of pathological inclusions.
inferredcites →https://doi.org/10.1111/j.1365-2982.2012.01887.xopenalex-snapshot
A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson’s disease
inferredcites →https://doi.org/10.1111/j.1750-3639.2012.00585.xopenalex-snapshot
Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type Synucleinopathies
inferredcites →https://doi.org/10.1111/j.1750-3639.2012.00597.xopenalex-snapshot
Critical Role of Truncated α‐Synuclein and Aggregates in Parkinson's Disease and Incidental Lewy Body Disease
inferredcites →https://doi.org/10.1111/jnc.14955openalex-snapshot
A simple, versatile and robust centrifugation‐based filtration protocol for the isolation and quantification of α‐synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α‐synuclein research
inferredcites →https://doi.org/10.1111/neup.12687openalex-snapshot
A novel SNCA E83Q mutation in a case of dementia with Lewy bodies and atypical frontotemporal lobar degeneration
inferredcites →https://doi.org/10.1111/nmo.14354openalex-snapshot
Comparison of commercially available antibodies for the detection of phosphorylated alpha‐synuclein in primary culture of ENS
inferredcites →https://doi.org/10.1126/science.1227157openalex-snapshot
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
inferredcites →https://doi.org/10.1126/scitranslmed.aar5280openalex-snapshot
The vermiform appendix impacts the risk of developing Parkinson’s disease
inferredcites →https://doi.org/10.1186/2047-9158-2-4openalex-snapshot
Can we clinically diagnose dementia with Lewy bodies yet?
inferredcites →https://doi.org/10.1186/s40478-016-0357-9openalex-snapshot
Novel antibodies to phosphorylated α-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes
inferredcites →https://doi.org/10.1186/s40478-018-0567-4openalex-snapshot
Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer’s disease
inferredcites →https://doi.org/10.1186/s40478-019-0679-5openalex-snapshot
LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
inferredcites →https://doi.org/10.1186/s40478-021-01281-9openalex-snapshot
Tyrosine 136 phosphorylation of α-synuclein aggregates in the Lewy body dementia brain: involvement of serine 129 phosphorylation by casein kinase 2
inferredcites →https://doi.org/10.12688/f1000research.10851.1openalex-snapshot
The challenges with the validation of research antibodies
inferredcites →https://doi.org/10.1371/journal.pone.0252635openalex-snapshot
Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein
inferredcites →https://doi.org/10.21769/bioprotoc.754openalex-snapshot
Subcellular Fractionation of Cultured Human Cell Lines
inferredcites →https://doi.org/10.3233/jpd-150670openalex-snapshot
Optimizing Western Blots for the Detection of Endogenous α-Synuclein in the Enteric Nervous System
inferredcites →https://doi.org/10.3233/jpd-223285openalex-snapshot
Comparative Analysis of Total Alpha-Synuclein (αSYN) Immunoassays Reveals That They Do Not Capture the Diversity of Modified αSYN Proteoforms
inferredcites →https://doi.org/10.3389/fnins.2019.00381openalex-snapshot
The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s Diseases
inferredcites →https://doi.org/10.3389/fnins.2019.00889openalex-snapshot
Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
inferredcites →https://doi.org/10.3390/jcm8101601openalex-snapshot
Plasma pS129-α-Synuclein Is a Surrogate Biofluid Marker of Motor Severity and Progression in Parkinson’s Disease
inferredcites →https://doi.org/10.3892/mmr.2019.10152openalex-snapshot
Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson's disease via regulation of α‑synuclein methylation
inferredcites →https://doi.org/10.7554/elife.48907openalex-snapshot
Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1038/s41531-022-00357-0openalex-snapshot
Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson’s disease and other synucleinopathies
inferred← citeshttps://doi.org/10.1038/s41531-023-00604-yopenalex-snapshot
Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.